Journal
DIABETIC MEDICINE
Volume 21, Issue 6, Pages 515-523Publisher
BLACKWELL PUBLISHING LTD
DOI: 10.1111/j.1464-5491.2004.01199.x
Keywords
atypical anti-psychotic drugs; delivery of care; diabetes; insulin resistance; schizophrenia
Categories
Ask authors/readers for more resources
The prevalence of diabetes is increased in patients with schizophrenia. Although many reasons, including hereditary and lifestyle factors, contribute to this association, recently there has been heightened interest in the subject because of the link between the use of the newer atypical anti-psychotic drugs and the development of diabetes. These drugs cause significant weight gain and this may be one of the mechanisms by which they increase incident diabetes. The increased prevalence of diabetes among people with schizophrenia has implications for the delivery of care by psychiatrists, diabetologists and primary care.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available